|
1
|
Zhou D, Huang C, Lin Z, Zhan S, Kong L,
Fang C and Li J: Macrophage polarization and function with emphasis
on the evolving roles of coordinated regulation of cellular
signaling pathways. Cell Signal. 26:192–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murray PJ, Allen JE, Biswas SK, Fisher EA,
Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence
T, et al: Macrophage activation and polarization: Nomenclature and
experimental guidelines. Immunity. 41:14–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verreck FA, de Boer T, Langenberg DM,
Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, Waal-Malefyt R
and Ottenhoff TH: Human IL-23-producing type 1 macrophages promote
but IL-10-producing type 2 macrophages subvert immunity to
(myco)bacteria. Proc Natl Acad Sci USA. 101:4560–4565. 2004;
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bouhlel MA, Derudas B, Rigamonti E,
Dièvart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx
N, et al: PPARgamma activation primes human monocytes into
alternative M2 macrophages with anti-inflammatory properties. Cell
Metab. 6:137–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tamiya T, Kashiwagi I, Takahashi R,
Yasukawa H and Yoshimura A: Suppressors of cytokine signaling
(SOCS) proteins and JAK/STAT pathways: Regulation of T-cell
inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol.
31:980–985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whyte CS, Bishop ET, Rückerl D,
Gaspar-Pereira S, Barker RN, Allen JE, Rees AJ and Wilson HM:
Suppressor of cytokine signaling (SOCS)1 is a key determinant of
differential macrophage activation and function. J Leukoc Biol.
90:845–854. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stoiber D, Kovarik P, Cohney S, Johnston
JA, Steinlein P and Decker T: Lipopolysaccharide induces in
macrophages the synthesis of the suppressor of cytokine signaling 3
and suppresses signal transduction in response to the activating
factor IFN-gamma. J Immunol. 163:2640–2647. 1999.PubMed/NCBI
|
|
8
|
Liu Y, Stewart KN, Bishop E, Marek CJ,
Kluth DC, Rees AJ and Wilson HM: Unique expression of suppressor of
cytokine signaling 3 is essential for classical macrophage
activation in rodents in vitro and in vivo. J Immunol.
180:6270–6278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arnold CE, Whyte CS, Gordon P, Barker RN,
Rees AJ and Wilson HM: A critical role for suppressor of cytokine
signalling 3 in promoting M1 macrophage activation and function in
vitro and in vivo. Immunology. 141:96–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prêle CM, Woodward EA, Bisley J,
Keith-Magee A, Nicholson SE and Hart PH: SOCS1 regulates the IFN
but not NFkappaB pathway in TLR-stimulated human monocytes and
macrophages. J Immunol. 181:8018–8026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He XD, Wang Y, Wu Q, Wang HX, Chen ZD,
Zheng RS, Wang ZS, Wang JB and Yang Y: Xuebijing protects rats from
sepsis challenged with Acinetobacter baumannii by promoting Annexin
A1 expression and inhibiting proinflammatory cytokines secretion.
Evid Based Complement Alternat Med. 2013:8049402013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Hu Z, Zhou B, Li X and Tao R:
Chinese herbal preparation Xuebijing potently inhibits inflammasome
activation in hepatocytes and ameliorates mouse liver
ischemia-reperfusion injury. PLoS One. 10:e01314362015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sprague AH and Khalil RA: Inflammatory
cytokines in vascular dysfunction and vascular disease. Biochem
Pharmacol. 8:539–552. 2009. View Article : Google Scholar
|
|
15
|
Murray PJ: The JAK-STAT signaling pathway:
Input and output integration. J Immunol. 178:2623–2629. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshimura A: Regulation of cytokine
signaling by the SOCS and Spred family proteins. Keio J Med.
58:73–83. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu YC, Yao FH, Chai YF, Dong N, Sheng ZY
and Yao YM: Xuebijing injection promotes M2 polarization of
macrophages and improves survival rate in septic mice. Evid Based
Complement Alternat Med. 2015:3526422015.PubMed/NCBI
|
|
18
|
Chen Z, Li F, Yang W, Liang Y, Tang H, Li
Z, Wu J, Liang H and Ma Z: Effect of rTsP53 on the M1/M2 activation
of bone-marrow derived macrophage in vitro. Int J Clin Exp Pathol.
8:13661–13676. 2015.PubMed/NCBI
|
|
19
|
Ouedraogo R, Daumas A, Ghigo E, Capo C,
Mege JL and Textoris J: Whole-cell MALDI-TOF MS: A new tool to
assess the multifaceted activation of macrophages. J Proteomics.
75:5523–5532. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu X, Chen J, Wang L and Ivashkiv LB:
Crosstalk among Jak-STAT, toll-like receptor and ITAM-dependent
pathways in macrophage activation. J Leukoc Biol. 82:237–243. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krebs DL and Hilton DJ: SOCS proteins:
Negative regulators of cytokine signaling. Stem Cells. 19:378–387.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wormald S and Hilton DJ: Inhibitors of
cytokine signal transduction. J Biol Chem. 279:821–824. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spence S, Fitzsimons A, Boyd CR, Kessler
J, Fitzgerald D, Elliott J, Gabhann JN, Smith S, Sica A, Hams E, et
al: Suppressors of cytokine signaling 2 and 3 diametrically control
macrophage polarization. Immunity. 38:66–78. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davey GM, Heath WR and Starr R: SOCS1: A
potent and multifaceted regulator of cytokines and cell-mediated
inflammation. Tissue Antigens. 67:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tajiri K, Imanaka-Yoshida K, Matsubara A,
Tsujimura Y, Hiroe M, Naka T, Shimojo N, Sakai S, Aonuma K and
Yasutomi Y: Suppressor of cytokine signaling 1 DNA administration
inhibits inflammatory and pathogenic responses in autoimmune
myocarditis. J Immunol. 189:2043–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hashimoto M, Ayada T, Kinjyo I, Hiwatashi
K, Yoshida H, Okada Y, Kobayashi T and Yoshimura A: Silencing of
SOCS1 in macrophages suppresses tumor development by enhancing
antitumor inflammation. Cancer Sci. 100:730–736. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Capello D, Gloghini A, Baldanzi G, Martini
M, Deambrogi C, Lucioni M, Piranda D, Famà R, Graziani A, Spina M,
et al: Alterations of negative regulators of cytokine signalling in
immunodeficiency-related non-Hodgkin lymphoma. Hematol Oncol.
31:22–28. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Souma Y, Nishida T, Serada S, Iwahori K,
Takahashi T, Fujimoto M, Ripley B, Nakajima K, Miyazaki Y, Mori M,
et al: Antiproliferative effect of SOCS-1 through the suppression
of STAT3 and p38 MAPK activation in gastric cancer cells. Int J
Cancer. 131:1287–1296. 2012. View Article : Google Scholar : PubMed/NCBI
|
